Palasis Maria 4
4 · Beta Bionics, Inc. · Filed Nov 5, 2025
Insider Transaction Report
Form 4
Palasis Maria
Director
Transactions
- Sale
Common Stock
2025-10-31$27.45/sh−119$3,267→ 9,841 total - Sale
Common Stock
2025-10-31$26.86/sh−1,287$34,567→ 9,960 total
Footnotes (3)
- [F1]Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2025.
- [F2]The weighted average sale price for the transaction reported was $26.8588 and the range of prices were between $26.27 and $27.22. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F3]The weighted average sale price for the transaction reported was $27.4502 and the range of prices were between $27.32 and $27.57. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.